Total Payments
$3,338
2019 Payments
$203.62
Companies
13
Transactions
36
Payment Breakdown by Category
Food & Beverage$3,338 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,338 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $652.66 | 6 | $0 (2018) |
| PFIZER INC. | $465.69 | 5 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $454.36 | 4 | $0 (2018) |
| Novo Nordisk Inc | $445.44 | 6 | $0 (2018) |
| Daiichi Sankyo Inc. | $312.66 | 3 | $0 (2017) |
| Amgen Inc. | $233.86 | 2 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $180.15 | 2 | $0 (2017) |
| Celgene Corporation | $160.58 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $154.00 | 2 | $0 (2019) |
| AbbVie, Inc. | $96.53 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $203.62 | 2 | PFIZER INC. ($104.08) |
| 2018 | $1,116 | 12 | AstraZeneca Pharmaceuticals LP ($350.18) |
| 2017 | $2,018 | 22 | SANOFI-AVENTIS U.S. LLC ($329.62) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $99.54 | General |
| Category: DIABETES | ||||||
| 02/28/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $104.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $42.52 | General |
| 08/15/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $72.40 | General |
| Category: Diabetes | ||||||
| 07/31/2018 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $100.12 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/09/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $39.34 | General |
| Category: Diabetes | ||||||
| 05/03/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: DIABETES | ||||||
| 04/04/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $117.19 | General |
| Category: Endocrinology | ||||||
| 03/28/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $106.98 | General |
| Category: Respiratory | ||||||
| 03/14/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $75.01 | General |
| Category: Diabetes | ||||||
| 01/30/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $96.53 | General |
| 01/25/2018 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $98.21 | General |
| Category: Dermatology | ||||||
| 11/29/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $54.46 | General |
| Category: DIABETES | ||||||
| 10/25/2017 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $99.54 | General |
| Category: DIABETES | ||||||
| 10/11/2017 | Gilead Sciences Inc | Ranexa (Drug) | Food and Beverage | In-kind items and services | $78.79 | General |
| Category: IHD | ||||||
| 08/10/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $78.35 | General |
| Category: Opioid Induced Constipation | ||||||
| 08/03/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: DIABETES | ||||||
| 07/19/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $86.96 | General |
| Category: Hyperkalemia | ||||||
| 06/21/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $91.17 | General |
| Category: Obesity | ||||||
| 06/14/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $97.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2017 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Otolaryngology | ||||||
| 06/06/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $62.37 | General |
| Category: Dermatology | ||||||
About Dr. Ivan Wolf, MD
Dr. Ivan Wolf, MD is a Occupational Medicine healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457479560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Wolf, MD has received a total of $3,338 in payments from pharmaceutical and medical device companies, with $203.62 received in 2019. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($3,338).
Ad
Practice Information
- Specialty Occupational Medicine
- Location Syracuse, NY
- Active Since 03/27/2007
- Last Updated 07/08/2007
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1457479560
Products in Payments
- FARXIGA (Drug) $455.68
- SOLIQUA (Drug) $454.36
- ELIQUIS (Drug) $297.81
- Movantik (Drug) $204.72
- NUEDEXTA (Drug) $180.15
- Otezla (Drug) $160.58
- JARDIANCE (Drug) $154.00
- Tresiba (Drug) $125.00
- Prolia (Biological) $117.19
- Repatha (Biological) $116.67
- Ozempic (Drug) $114.35
- INJECTAFER (Drug) $107.94
- BEVESPI AEROSPHERE (Drug) $106.98
- CHANTIX (Drug) $100.12
- Saxenda (Drug) $91.17
- BYDUREON (Drug) $90.00
- Veltassa (Drug) $86.96
- Ranexa (Drug) $78.79
- Victoza (Drug) $72.40
- LYRICA (Drug) $67.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.